Hillevax Inc
HilleVax, Inc., a clinical-stage biopharmaceutical company, develops and commercializes vaccines in the United States. The company develops HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. It has a license agreement with Takeda Vaccines, Inc. to develop and commercialize HIL-214 pharmaceutical prod… Read more
Market Cap & Net Worth: Hillevax Inc (HLVX)
Hillevax Inc (NASDAQ:HLVX) has a market capitalization of $104.76 Million ($104.76 Million) as of March 19, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #19013 globally and #7017 in its home market, demonstrating a -0.48% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Hillevax Inc's stock price $2.09 by its total outstanding shares 50125541 (50.13 Million).
Hillevax Inc Market Cap History: 2022 to 2025
Hillevax Inc's market capitalization history from 2022 to 2025. Data shows change from $838.60 Million to $104.76 Million (-47.94% CAGR).
Index Memberships
Hillevax Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.24 Trillion | 0.00% | #521 of 976 |
|
NASDAQ Composite
IXIC
|
$33.39 Trillion | 0.00% | #1748 of 3165 |
Weight: Hillevax Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Hillevax Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Hillevax Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of HLVX by Market Capitalization
Companies near Hillevax Inc in the global market cap rankings as of March 19, 2026.
Key companies related to Hillevax Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Hillevax Inc Historical Marketcap From 2022 to 2025
Between 2022 and today, Hillevax Inc's market cap moved from $838.60 Million to $ 104.76 Million, with a yearly change of -47.94%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $104.76 Million | +0.97% |
| 2024 | $103.76 Million | -87.10% |
| 2023 | $804.51 Million | -4.06% |
| 2022 | $838.60 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Hillevax Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $104.76 Million USD |
| MoneyControl | $104.76 Million USD |
| MarketWatch | $104.76 Million USD |
| marketcap.company | $104.76 Million USD |
| Reuters | $104.76 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.